There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. After-hours trades for Precision BioSciences Inc. (DTIL) shows that investor sentiment remained same, with the stock’s consolidated last price remained same to $1.23. The Precision BioSciences Inc. has recorded 1,667 volume in the after hours trading session. The stock was recently discussed on Yahoo Finance as it revealed that Precision BioSciences Recaps 2022 Accomplishments and Outlines 2023 Corporate Priorities and Planned Portfolio Milestones.
This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. At the end of the last regular session, the stock closed at $1.23 and fluctuated between $1.2500 as its day high and $1.2000 as its day low. The current market capitalization of Precision BioSciences Inc. is $137.64M. A total of 0.62 million shares were traded on the day, compared to an average of 570.43K shares.
Insider trades can also provide insight into a stock’s future direction. During the recent three months, DTIL has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 15 BUYs and 3 SELLs from insiders. Insiders purchased 252,737 shares during that period but sold 39,688.
In the most recent transaction, Amoroso Michael sold 11,006 shares of DTIL for 1.32 per share on Oct 17. After the transaction, the President and CEO now owns 13,202 company shares. In a previous transaction on Sep 23, Kelly John Alexander bought 8,200 shares at 1.23 per share. DTIL shares that Chief Financial Officer owns now total 162,938.
Among the insiders who bought shares, Kelly John Alexander acquired of 37,037 shares on Sep 22 at a per-share price of $1.34. This resulted in the Chief Financial Officer holding 154,738 shares of DTIL after the transaction. In another insider transaction, Kelly John Alexander bought 33,784 shares at $1.50 per share on Jun 22. Company shares held by the Chief Financial Officer now total 117,701.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. According to analysts who have offered 12-month price targets for DTIL in the last 3 months, the mean price target is $6.38 with high estimates of $17.00 and low estimates of $1.00. In terms of 52-week highs and lows, DTIL has a high of $5.20 and a low of $0.95.
As of this writing, DTIL has an earnings estimate of -$0.26 per share for the current quarter. EPS was calculated based on a consensus of 8 estimates, with a high estimate of $0.37 per share and a lower estimate of -$0.48. The company reported an EPS of -$0.46 in the last quarter, which was 14.80% higher than expectations of -$0.54.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects.
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 9 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for DTIL is Overweight with a score of 4.33. A total of 6 analysts rated the stock as Buy while 0 rated it as Overweight while 3 rated it as Hold. Among the other participants, 0 thought the stock was Underweight and 0 thought it should be Sold.